Trump Media & Technology (DJTWW) had the highest return between January 1, 2024 and January 30, 2024 by a mid-cap US stock or mid-cap US stock, returning 171.5%.
| ASSET | DATE | % RETURN |
|---|---|---|
Trump Media & Technology (DJTWW) | 1/1/2024 - 1/30/2024 | 171.46% |
Dave (DAVE) | 1/1/2024 - 1/30/2024 | 114.48% |
Trump Media & Technology (DJT) | 1/1/2024 - 1/30/2024 | 114.29% |
Sezzle (SEZL) | 1/1/2024 - 1/30/2024 | 85.53% |
Arcutis Biotherapeutics (ARQT) | 1/1/2024 - 1/30/2024 | 85.17% |
NewAmsterdam Pharma Company NV Ordinary Shares (NAMS) | 1/1/2024 - 1/30/2024 | 78.04% |
Dyne Therapeutics (DYN) | 1/1/2024 - 1/30/2024 | 62.67% |
Advantage Solutions (ADVWW) | 1/1/2024 - 1/30/2024 | 43.01% |
Oscar Health (OSCR) | 1/1/2024 - 1/30/2024 | 41.86% |
GeneDx (WGS) | 1/1/2024 - 1/30/2024 | 39.63% |
Tarsus Pharmaceuticals (TARS) | 1/1/2024 - 1/30/2024 | 37.45% |
Innodata (INOD) | 1/1/2024 - 1/30/2024 | 35.63% |
Rumble (RUM) | 1/1/2024 - 1/30/2024 | 35.33% |
Merus (MRUS) | 1/1/2024 - 1/30/2024 | 31.76% |
Alvotech (ALVO) | 1/1/2024 - 1/30/2024 | 31.68% |
Appfolio (APPF) | 1/1/2024 - 1/30/2024 | 31.1% |
Avidity Biosciences (RNA) | 1/1/2024 - 1/30/2024 | 30.82% |
Kymera Therapeutics (KYMR) | 1/1/2024 - 1/30/2024 | 28.73% |
Viking Therapeutics (VKTX) | 1/1/2024 - 1/30/2024 | 28.55% |
Mineralys Therapeutics, Inc Common Stock (MLYS) | 1/1/2024 - 1/30/2024 | 27.8% |
WM Technology (MAPSW) | 1/1/2024 - 1/30/2024 | 27.5% |
Sanmina (SANM) | 1/1/2024 - 1/30/2024 | 27.5% |
CG Oncology, Inc Common stock (CGON) | 1/1/2024 - 1/30/2024 | 25.86% |
Kemper (KMPR) | 1/1/2024 - 1/30/2024 | 25.85% |
Grupo Financiero Galicia SA ADR (GGAL) | 1/1/2024 - 1/30/2024 | 25.33% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
